Patients' acceptance of CareLink home telemonitoring system

2 for T-wave oversensing, and 1 for interference).Complications were encountered in 5 patients (7%) (1 had a pneumothorax post implantation and 4 were device related). Conclusion: In a routine clinical heart failure population, prophylactic ICD implantation provided appropriate therapy for potentially lifethreatening arrhythmias in 25% of the population over a two year follow up, a rate similar to that reported in the clinical trials. With a relatively low complication rate these data indicate translation of clinical trial benefits to the general heart failure population.